Registration now open for BOS Events 2025!

Dates for BOS Events 2025 are 11th and 12th June for BOS Basel 2025, and 25th and 26th November for BOS Manchester 2025. Please find further details outlining floor plans and pricing options at the event links provided.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Enabling Robust Impurity Rejection and Form Control in the Crystallization of a Small Molecule API by Switching from Batch to Continuous Processing

Mr firstname_2325 lastname_2325, Senior Process Development Engineer, companyname_2325

ABSTRACT: Within the past decade the pharmaceutical industry has embraced the implementation of continuous processing as part of a concerted effort to modernize the methods by which therapeutic products are developed and manufactured (Burcham et al., 2018). In the production of small molecule active pharmaceutical ingredients (APIs), numerous product quality, safety, sustainability, and cost benefits can be realized by parting ways with antiquated batch processing methods and focusing new synthetic routes towards continuous processing infrastructure.
In this presentation, APC discusses the opportunity... Click here to Read More

Registration now open for BOS Events 2025!

Featured Speaker (BOS Manchester 2025)

Enabling Robust Impurity Rejection and Form Control in the Crystallization of a Small Molecule API by Switching from Batch to Continuous Processing

Mr firstname_2325 lastname_2325, Senior Process Development Engineer, companyname_2325